Neurovascular Devices/Interventional Neurology Market : Global Industry Analysis and Forecast-2023-2029


Global Neurovascular Devices/Interventional Neurology Market is expected to reach US$ 4.96 Bn. at a CAGR of 5%during the forecast period 2029.

Global Neurovascular Devices/Interventional Neurology Market introduction and Overview

Neurovascular/interventional neurology devices are used to treat several neurovascular diseases (including aneurysms, arteriovenous malformations and atherosclerosis) that affect the central nervous system as well as the blood vascular system associated with it.

Therapeutic procedures are increasingly being adopted for better diagnosis, monitoring and therapy for neurological conditions because of their proven efficacy. This is one of the major reasons for increasing adoption of interventional neurology products. These products are adopted globally by majority of neurosurgeons and medical professionals in key markets such as the U.S, Germany, France and UK. Significant consumption value of neurovascular devices and rapidly growing patient population are expected to boost the market growth. The increasing prevalence of cancers, strokes and other malformations has made the innovation of advanced technologies mandatory. Changing sedentary lifestyle, high blood pressure, smoking, obesity are resulting in rising cases of neurological or neurovascular diseases.

Neurovascular Device Neurology MarketTo know about the Research Methodology :- Request Free Sample Report

According to a country wise analysis, the number of cases of brain aneurysm and ischemic strokes are increasing rapidly in developing as well as developed economies. There is a rise in demand for minimally invasive surgical procedures, also technological advancements in neurovascular treatments are taking place. Moreover, government initiatives to modernize healthcare infrastructure across the globe are also expected to drive the market upwards. All the above mentioned factors are responsible for the Neurovascular Devices/Interventional Neurology Market to grow at a rapid pace in the forecast period.

However, the chief markets such as the U.S., Germany, and Japan have a limited number of neurosurgeons with the required skills and experience to perform surgical clipping or endoscopy to treat complex cerebral aneurysms. In terms of providing training, healthcare providers across these markets have been unable to match the ongoing technological advancements and expansion of patient base.

Thus, the inadequacy of skilled and experienced neurosurgeons is restraining the adoption of neurovascular devices/interventional neurology.

The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Neurovascular Devices/Interventional Neurology Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges.

The report has profiled seventeen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.

Global Neurovascular Devices/Interventional Neurology Market Segment Analysis

The aneurysm coiling and embolization devices segment is expected to account for the largest market share of xx% in the forecast period. Coil embolization is a minimally invasive procedure to treat an aneurysm by filling it with material that closes off the sac and reduces the risk of bleeding. It is performed from "within" the artery (endovascular) through a steerable catheter inserted into the blood stream at the groin and guided to the brain. The increasing frequency of unruptured intracranial aneurysm detection and rising focus on new product launches are expected to boost the segment growth. Moreover, high demand for minimally invasive neurosurgical procedures and availability of embolic coils are also augmenting the market growth.

On the basis of disease pathology, the market is segmented into ischemic strokes, cerebral aneurysm, arteriovenous malfunctions and fistulas and other diseases. The ischemic stroke segment is expected to grow at a highest CAGR of xx% during the forecast period. The growing incidences of ischemic strokes and increasing preference for minimally invasive surgeries by patients, the segment is expected to grow upwards.This type of stroke is caused by a blockage in an artery that supplies blood to the brain. The blockage reduces the blood flow and oxygen to the brain, leading to damage or death of brain cells. Such strokes are treated with minimum invasive procedures such as diagnostic angiography, cerebral balloon angioplasty and stent placement.

Global Neurovascular Devices/Interventional Neurology Market Regional Insights

Global Neurovascular Devices-Interventional Neurology Market1

North America generated a revenue of $xx Mn in 2020 and is expected to emerge as a dominant region in the forecast period. Increasing prevalence of strokes,rising awareness among neurosurgeons related to the benefits offered by interventional neurology devicesgrowing research activities, advanced treatment techniques and high class healthcare facilities available are boosting the market in the region.

Asia Pacific is expected to witness growth in the forecast period. Owing to the increasing population and growing healthcare facilities in developing nations the market in this region is anticipated to grow.

The report also helps in understanding Global Neurovascular Devices/Interventional Neurology Marketdynamics, structure by analysing the market segments and project the Global Neurovascular Devices/Interventional Neurology Marketsize. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Neurovascular Devices/Interventional Neurology Marketmake the report investor’s guide.

Neurovascular Devices/Interventional Neurology Market Scope: Inquire before buying






Neurovascular Devices/Interventional Neurology Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 3.53 Bn.




Forecast Period 2023 to 2029 CAGR:
 5%
Market Size in 2029:
US $ 4.96 Bn.




 Segments Covered:
by Product
Aneurysm Coiling & Embolization Devices
Embolic coils
Flow diversion devices
Liquid embolic agents
Cerebral Balloon angioplasty and stenting systems
Support devices
Neurothrombectomy devices




by Type
Ischemic Strokes
Cerebral Aneurysms
Arteriovenous Malformation and Fistulas
Other Disease pathology






Neurovascular Devices/Interventional Neurology Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Players operating in the Global Neurovascular Devices/Interventional Neurology Market

1. Stryker Corporation
2. Medtronic plc
3. Johnson & Johnson
4. Terumo Corporation
5. Penumbra, Inc
6. Abbott Laboratories
7. Merit Medical Systems, Inc
8. W.L Gore & Associates, Inc
9. Microport Scientific Corporation
10.B. Braun Melsungen AG
11.Cook
12.Uresil, LLC
13.Medikit Co Ltd
14.Bayer AG
15.Acandis GmbH
16.Biosensors International group Ltd
17.Integra Life sciences Corporation
18.Others

Frequently Asked Questions:

1. Which region has the largest share in Global Neurovascular Devices/Interventional Neurology Market?
Ans: Asia Pacific region held the highest share in 2022.

2. What is the growth rate of Global Neurovascular Devices/Interventional Neurology Market?
Ans: The Global Neurovascular Devices/Interventional Neurology Market is growing at a CAGR of 5% during forecasting period 2023-2029.

3. What is scope of the Global Neurovascular Devices/Interventional Neurology Market report?
Ans: Global Neurovascular Devices/Interventional Neurology Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors& Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Neurovascular Devices/Interventional Neurology Market?
Ans: The important key players in the Global Neurovascular Devices/Interventional Neurology Market are – Denso Corporation, Hanon Systems, Sanden Holding Corporation, Mitsubishi Heavy Industries Ltd, MAHLE GmbH, Valeo SA, Keihin Corporation, Calsonic Kansei Corporation, SamvardhanaMotherson Group, Subros Limited, SMAC Auto Air, TransAir Manufacturing, Eberspacher Group, Marelli Corporation.

5. What is the study period of this Market?
Ans: The Global Neurovascular Devices/Interventional Neurology Market is studied from 2022 to 2029. 





Global Neurovascular Devices/Interventional Neurology Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Size, By Market Value (US$ Mn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators

6. Global NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis and Forecast
6.1. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis and Forecast, By Product
7.1. Introduction and Definition
7.2. Key Findings
7.3. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Product
7.4. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Size (US$ Mn) Forecast, By Product
7.5. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Product
7.6. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis, By Product

8. Global NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis and Forecast, By Disease Pathology
8.1. Introduction and Definition
8.2. Key Findings
8.3. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Disease Pathology
8.4. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Size (US$ Mn) Forecast, By Disease Pathology
8.5. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Disease Pathology
8.6. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis, By Disease Pathology

9. Global NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Region
9.1. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Region
9.2. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Size (US$ Mn) Forecast, By Region
9.3. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis, By Region

10. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis
10.1. Key Findings
10.2. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Overview
10.3. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Product
10.4. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
10.4.1. Aneurysm Coiling & Embolization Devices
10.4.2. Cerebral Balloon angioplasty and stenting systems
10.4.3. Support devices
10.4.4. Neurothrombectomy devices
10.5. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Disease Pathology
10.6. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
10.6.1. Ischemic Strokes
10.6.2. Cerebral Aneurysms
10.6.3. Arteriovenous Malformation and Fistulas
10.6.4. Other Disease pathology
10.7. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Country
10.8. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Country
10.8.1. U.S.
10.8.2. Canada
10.8.3. Mexico
10.9. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Country
10.10. U.S. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
10.10.1. Aneurysm Coiling & Embolization Devices
10.10.2. Cerebral Balloon angioplasty and stenting systems
10.10.3. Support devices
10.10.4. Neurothrombectomy devices
10.11. U.S. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
10.11.1. Ischemic Strokes
10.11.2. Cerebral Aneurysms
10.11.3. Arteriovenous Malformation and Fistulas
10.11.4. Other Disease pathology
10.12. Canada NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
10.12.1. Aneurysm Coiling & Embolization Devices
10.12.2. Cerebral Balloon angioplasty and stenting systems
10.12.3. Support devices
10.12.4. Neurothrombectomy devices
10.13. Canada NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
10.13.1. Ischemic Strokes
10.13.2. Cerebral Aneurysms
10.13.3. Arteriovenous Malformation and Fistulas
10.13.4. Other Disease pathology
10.14. Mexico NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
10.14.1. Aneurysm Coiling & Embolization Devices
10.14.2. Cerebral Balloon angioplasty and stenting systems
10.14.3. Support devices
10.14.4. Neurothrombectomy devices
10.15. Mexico NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
10.15.1. Ischemic Strokes
10.15.2. Cerebral Aneurysms
10.15.3. Arteriovenous Malformation and Fistulas
10.15.4. Other Disease pathology
10.16. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis
10.16.1. By Product
10.16.2. By Disease Pathology
10.17. PEST Analysis
10.18. Key Trends
10.19. Key Developments

11. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis
11.1. Key Findings
11.2. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Overview
11.3. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Product
11.4. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
11.4.1. Aneurysm Coiling & Embolization Devices
11.4.2. Cerebral Balloon angioplasty and stenting systems
11.4.3. Support devices
11.4.4. Neurothrombectomy devices
11.5. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Disease Pathology
11.6. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
11.6.1. Ischemic Strokes
11.6.2. Cerebral Aneurysms
11.6.3. Arteriovenous Malformation and Fistulas
11.6.4. Other Disease pathology
11.7. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Country
11.8. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Country
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Sweden
11.8.7. CIS countries
11.8.8. Rest of Europe
11.9. Germany NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
11.9.1. Aneurysm Coiling & Embolization Devices
11.9.2. Cerebral Balloon angioplasty and stenting systems
11.9.3. Support devices
11.9.4. Neurothrombectomy devices
11.10. Germany NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
11.10.1. Ischemic Strokes
11.10.2. Cerebral Aneurysms
11.10.3. Arteriovenous Malformation and Fistulas
11.10.4. Other Disease pathology
11.11. U.K. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
11.11.1. Aneurysm Coiling & Embolization Devices
11.11.2. Cerebral Balloon angioplasty and stenting systems
11.11.3. Support devices
11.11.4. Neurothrombectomy devices
11.12. U.K. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
11.12.1. Ischemic Strokes
11.12.2. Cerebral Aneurysms
11.12.3. Arteriovenous Malformation and Fistulas
11.12.4. Other Disease pathology
11.13. France NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
11.13.1. Aneurysm Coiling & Embolization Devices
11.13.2. Cerebral Balloon angioplasty and stenting systems
11.13.3. Support devices
11.13.4. Neurothrombectomy devices
11.14. France NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
11.14.1. Ischemic Strokes
11.14.2. Cerebral Aneurysms
11.14.3. Arteriovenous Malformation and Fistulas
11.14.4. Other Disease pathology
11.15. Italy NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
11.15.1. Aneurysm Coiling & Embolization Devices
11.15.2. Cerebral Balloon angioplasty and stenting systems
11.15.3. Support devices
11.15.4. Neurothrombectomy devices
11.16. Italy NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
11.16.1. Ischemic Strokes
11.16.2. Cerebral Aneurysms
11.16.3. Arteriovenous Malformation and Fistulas
11.16.4. Other Disease pathology
11.17. Spain NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
11.17.1. Aneurysm Coiling & Embolization Devices
11.17.2. Cerebral Balloon angioplasty and stenting systems
11.17.3. Support devices
11.17.4. Neurothrombectomy devices
11.18. Spain NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
11.18.1. Ischemic Strokes
11.18.2. Cerebral Aneurysms
11.18.3. Arteriovenous Malformation and Fistulas
11.18.4. Other Disease pathology
11.19. Sweden NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
11.19.1. Aneurysm Coiling & Embolization Devices
11.19.2. Cerebral Balloon angioplasty and stenting systems
11.19.3. Support devices
11.19.4. Neurothrombectomy devices
11.20. Sweden NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
11.20.1. Ischemic Strokes
11.20.2. Cerebral Aneurysms
11.20.3. Arteriovenous Malformation and Fistulas
11.20.4. Other Disease pathology
11.21. CIS countries NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
11.21.1. Aneurysm Coiling & Embolization Devices
11.21.2. Cerebral Balloon angioplasty and stenting systems
11.21.3. Support devices
11.21.4. Neurothrombectomy devices
11.22. CIS countries NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
11.22.1. Ischemic Strokes
11.22.2. Cerebral Aneurysms
11.22.3. Arteriovenous Malformation and Fistulas
11.22.4. Other Disease pathology
11.23. Rest of Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
11.23.1. Aneurysm Coiling & Embolization Devices
11.23.2. Cerebral Balloon angioplasty and stenting systems
11.23.3. Support devices
11.23.4. Neurothrombectomy devices
11.24. Rest of Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
11.24.1. Ischemic Strokes
11.24.2. Cerebral Aneurysms
11.24.3. Arteriovenous Malformation and Fistulas
11.24.4. Other Disease pathology
11.25. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis
11.25.1. By Disease Pathology
11.25.2. By Product
11.26. PEST Analysis
11.27. Key Trends
11.28. Key Developments

12. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis
12.1. Key Findings
12.2. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Overview
12.3. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Product
12.4. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
12.4.1. Aneurysm Coiling & Embolization Devices
12.4.2. Cerebral Balloon angioplasty and stenting systems
12.4.3. Support devices
12.4.4. Neurothrombectomy devices
12.5. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Disease Pathology
12.6. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
12.6.1. Ischemic Strokes
12.6.2. Cerebral Aneurysms
12.6.3. Arteriovenous Malformation and Fistulas
12.6.4. Other Disease pathology
12.7. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Country
12.8. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. South Korea
12.8.5. Australia
12.8.6. ASEAN
12.8.7. Rest of Asia Pacific
12.9. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Country
12.10. China NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
12.10.1. Aneurysm Coiling & Embolization Devices
12.10.2. Cerebral Balloon angioplasty and stenting systems
12.10.3. Support devices
12.10.4. Neurothrombectomy devices
12.11. China NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
12.11.1. Ischemic Strokes
12.11.2. Cerebral Aneurysms
12.11.3. Arteriovenous Malformation and Fistulas
12.11.4. Other Disease pathology
12.12. India NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
12.12.1. Aneurysm Coiling & Embolization Devices
12.12.2. Cerebral Balloon angioplasty and stenting systems
12.12.3. Support devices
12.12.4. Neurothrombectomy devices
12.13. India NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
12.13.1. Ischemic Strokes
12.13.2. Cerebral Aneurysms
12.13.3. Arteriovenous Malformation and Fistulas
12.13.4. Other Disease pathology
12.14. Japan NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
12.14.1. Aneurysm Coiling & Embolization Devices
12.14.2. Cerebral Balloon angioplasty and stenting systems
12.14.3. Support devices
12.14.4. Neurothrombectomy devices
12.15. Japan NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
12.15.1. Ischemic Strokes
12.15.2. Cerebral Aneurysms
12.15.3. Arteriovenous Malformation and Fistulas
12.15.4. Other Disease pathology
12.16. South Korea NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
12.16.1. Aneurysm Coiling & Embolization Devices
12.16.2. Cerebral Balloon angioplasty and stenting systems
12.16.3. Support devices
12.16.4. Neurothrombectomy devices
12.17. South Korea NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
12.17.1. Ischemic Strokes
12.17.2. Cerebral Aneurysms
12.17.3. Arteriovenous Malformation and Fistulas
12.17.4. Other Disease pathology
12.18. Australia NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
12.18.1. Aneurysm Coiling & Embolization Devices
12.18.2. Cerebral Balloon angioplasty and stenting systems
12.18.3. Support devices
12.18.4. Neurothrombectomy devices
12.19. Australia NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
12.19.1. Ischemic Strokes
12.19.2. Cerebral Aneurysms
12.19.3. Arteriovenous Malformation and Fistulas
12.19.4. Other Disease pathology
12.20. ASEAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
12.20.1. Aneurysm Coiling & Embolization Devices
12.20.2. Cerebral Balloon angioplasty and stenting systems
12.20.3. Support devices
12.20.4. Neurothrombectomy devices
12.21. ASEAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
12.21.1. Ischemic Strokes
12.21.2. Cerebral Aneurysms
12.21.3. Arteriovenous Malformation and Fistulas
12.21.4. Other Disease pathology
12.22. Rest of Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
12.22.1. Aneurysm Coiling & Embolization Devices
12.22.2. Cerebral Balloon angioplasty and stenting systems
12.22.3. Support devices
12.22.4. Neurothrombectomy devices
12.23. Rest of Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
12.23.1. Ischemic Strokes
12.23.2. Cerebral Aneurysms
12.23.3. Arteriovenous Malformation and Fistulas
12.23.4. Other Disease pathology
12.24. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis
12.24.1. By Product
12.24.2. By Disease Pathology
12.25. PEST Analysis
12.26. Key Trends
12.27. Key Developments

13. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis
13.1. Key Findings
13.2. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Overview
13.3. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Product
13.4. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
13.4.1. Aneurysm Coiling & Embolization Devices
13.4.2. Cerebral Balloon angioplasty and stenting systems
13.4.3. Support devices
13.4.4. Neurothrombectomy devices
13.5. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Disease Pathology
13.6. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
13.6.1. Ischemic Strokes
13.6.2. Cerebral Aneurysms
13.6.3. Arteriovenous Malformation and Fistulas
13.6.4. Other Disease pathology
13.7. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Country
13.8. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Country
13.8.1. GCC Countries
13.8.2. South Africa
13.8.3. Nigeria
13.8.4. Egypt
13.8.5. Rest of Middle East & Africa
13.9. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Country
13.10. GCC Countries NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
13.10.1. Aneurysm Coiling & Embolization Devices
13.10.2. Cerebral Balloon angioplasty and stenting systems
13.10.3. Support devices
13.10.4. Neurothrombectomy devices
13.11. GCC Countries NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
13.11.1. Ischemic Strokes
13.11.2. Cerebral Aneurysms
13.11.3. Arteriovenous Malformation and Fistulas
13.11.4. Other Disease pathology
13.12. South Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
13.12.1. Aneurysm Coiling & Embolization Devices
13.12.2. Cerebral Balloon angioplasty and stenting systems
13.12.3. Support devices
13.12.4. Neurothrombectomy devices
13.13. South Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
13.13.1. Ischemic Strokes
13.13.2. Cerebral Aneurysms
13.13.3. Arteriovenous Malformation and Fistulas
13.13.4. Other Disease pathology
13.14. Nigeria NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
13.14.1. Aneurysm Coiling & Embolization Devices
13.14.2. Cerebral Balloon angioplasty and stenting systems
13.14.3. Support devices
13.14.4. Neurothrombectomy devices
13.15. Nigeria NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
13.15.1. Ischemic Strokes
13.15.2. Cerebral Aneurysms
13.15.3. Arteriovenous Malformation and Fistulas
13.15.4. Other Disease pathology
13.16. Egypt NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
13.16.1. Aneurysm Coiling & Embolization Devices
13.16.2. Cerebral Balloon angioplasty and stenting systems
13.16.3. Support devices
13.16.4. Neurothrombectomy devices
13.17. Egypt NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
13.17.1. Ischemic Strokes
13.17.2. Cerebral Aneurysms
13.17.3. Arteriovenous Malformation and Fistulas
13.17.4. Other Disease pathology
13.18. Rest of Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
13.18.1. Aneurysm Coiling & Embolization Devices
13.18.2. Cerebral Balloon angioplasty and stenting systems
13.18.3. Support devices
13.18.4. Neurothrombectomy devices
13.19. Rest of Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
13.19.1. Ischemic Strokes
13.19.2. Cerebral Aneurysms
13.19.3. Arteriovenous Malformation and Fistulas
13.19.4. Other Disease pathology
13.20. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis
13.20.1. By Product
13.20.2. By Disease Pathology
13.21. PEST Analysis
13.22. Key Trends
13.23. Key Developments

14. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis
14.1. Key Findings
14.2. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Overview
14.3. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Product
14.4. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
14.4.1. Aneurysm Coiling & Embolization Devices
14.4.2. Cerebral Balloon angioplasty and stenting systems
14.4.3. Support devices
14.4.4. Neurothrombectomy devices
14.5. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Disease Pathology
14.6. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
14.6.1. Ischemic Strokes
14.6.2. Cerebral Aneurysms
14.6.3. Arteriovenous Malformation and Fistulas
14.6.4. Other Disease pathology
14.7. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Country
14.8. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Country
14.8.1. Brazil
14.8.2. Colombia
14.8.3. Argentina
14.8.4. Rest of South America
14.9. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Country
14.10. Brazil NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
14.10.1. Aneurysm Coiling & Embolization Devices
14.10.2. Cerebral Balloon angioplasty and stenting systems
14.10.3. Support devices
14.10.4. Neurothrombectomy devices
14.11. Brazil NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
14.11.1. Ischemic Strokes
14.11.2. Cerebral Aneurysms
14.11.3. Arteriovenous Malformation and Fistulas
14.11.4. Other Disease pathology
14.12. Colombia NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
14.12.1. Aneurysm Coiling & Embolization Devices
14.12.2. Cerebral Balloon angioplasty and stenting systems
14.12.3. Support devices
14.12.4. Neurothrombectomy devices
14.13. Colombia NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
14.13.1. Ischemic Strokes
14.13.2. Cerebral Aneurysms
14.13.3. Arteriovenous Malformation and Fistulas
14.13.4. Other Disease pathology
14.14. Argentina NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
14.14.1. Aneurysm Coiling & Embolization Devices
14.14.2. Cerebral Balloon angioplasty and stenting systems
14.14.3. Support devices
14.14.4. Neurothrombectomy devices
14.15. Argentina NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
14.15.1. Ischemic Strokes
14.15.2. Cerebral Aneurysms
14.15.3. Arteriovenous Malformation and Fistulas
14.15.4. Other Disease pathology
14.16. Rest of South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product
14.16.1. Aneurysm Coiling & Embolization Devices
14.16.2. Cerebral Balloon angioplasty and stenting systems
14.16.3. Support devices
14.16.4. Neurothrombectomy devices
14.17. Rest of South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology
14.17.1. Ischemic Strokes
14.17.2. Cerebral Aneurysms
14.17.3. Arteriovenous Malformation and Fistulas
14.17.4. Other Disease pathology
14.18. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis
14.18.1. By Product
14.18.2. By Disease Pathology
14.19. PEST Analysis
14.20. Key Trends
14.21. Key Developments

15. Company Profiles
15.1. Market Share Analysis, By Company
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players By price, presence, market share, Disease Pathology, and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Market Consolidation
15.2.3.1. M&A By Regions, Investment and Disease Pathology
15.2.3.2. M&A Key Players, Forward Integration and Backward Integration
15.3. Company Profiles: Key Players
15.3.1. Stryker Corporation
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Development Footprint
15.3.2. Medtronic plc
15.3.3. Johnson & Johnson
15.3.4. Terumo Corporation
15.3.5. Penumbra, Inc
15.3.6. Abbott Laboratories
15.3.7. Merit Medical Systems, Inc
15.3.8. W.L Gore & Associates, Inc
15.3.9. Microport Scientific Corporation
15.3.10. B. Braun Melsungen AG
15.3.11. Cook
15.3.12. Uresil, LLC
15.3.13. Medikit Co Ltd
15.3.14. Bayer AG
15.3.15. Acandis GmbH
15.3.16. Biosensors International group Ltd
15.3.17. Integra Life sciences Corporation
15.3.18. Others
  • INQUIRE BEFORE BUYING